Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
biological and medical sciences (35174) 35174
medical sciences (35174) 35174
sarcoidosis. granulomatous diseases of unproved etiology. connective tissue diseases. elastic tissue diseases. vasculitis (35174) 35174
humans (30211) 30211
science & technology (25988) 25988
life sciences & biomedicine (25966) 25966
female (20897) 20897
male (17859) 17859
adult (14654) 14654
middle aged (12712) 12712
abridged index medicus (9671) 9671
rheumatology (7789) 7789
fundamental and applied biological sciences. psychology (7702) 7702
aged (7271) 7271
fundamental immunology (7251) 7251
immunology (7193) 7193
allergy (5803) 5803
adolescent (5578) 5578
dermatology (4529) 4529
child (4477) 4477
immunopathology (3852) 3852
allergy and immunology (3769) 3769
diseases of the osteoarticular system (3717) 3717
animals (3258) 3258
systemic lupus erythematosus (3004) 3004
child, preschool (2787) 2787
lupus erythematosus, systemic - immunology (2515) 2515
risk factors (2232) 2232
treatment outcome (2205) 2205
asthma (2177) 2177
cardiology. vascular system (2129) 2129
pneumology (2076) 2076
allergies (2032) 2032
lupus erythematosus, systemic - complications (1993) 1993
retrospective studies (1902) 1902
diagnosis, differential (1868) 1868
pediatrics (1864) 1864
infant (1861) 1861
cardiovascular system & cardiology (1835) 1835
severity of illness index (1814) 1814
follow-up studies (1797) 1797
general aspects (1772) 1772
aged, 80 and over (1720) 1720
mice (1699) 1699
biopsy (1678) 1678
young adult (1675) 1675
case-control studies (1572) 1572
blood and lymphatic vessels (1557) 1557
general & internal medicine (1521) 1521
chronic obstructive pulmonary disease, asthma (1299) 1299
enzyme-linked immunosorbent assay (1270) 1270
analysis (1262) 1262
prognosis (1235) 1235
prospective studies (1229) 1229
cardiac & cardiovascular systems (1206) 1206
medicine, general & internal (1186) 1186
peripheral vascular disease (1169) 1169
studies (1169) 1169
children (1165) 1165
cohort studies (1165) 1165
lupus (1154) 1154
skin - pathology (1151) 1151
cells, cultured (1144) 1144
allergic diseases (1119) 1119
allergens - immunology (1089) 1089
sarcoidosis (1082) 1082
prevalence (1079) 1079
respiratory system (1042) 1042
vasculitis (1031) 1031
care and treatment (1028) 1028
health aspects (1001) 1001
scleroderma, systemic - complications (994) 994
scleroderma (985) 985
diseases of the peripheral vessels. diseases of the vena cava. miscellaneous (974) 974
time factors (970) 970
diagnosis (967) 967
tomography, x-ray computed (957) 957
medical colleges (955) 955
systemic sclerosis (954) 954
immunosuppressive agents - therapeutic use (940) 940
immunoglobulin e - blood (923) 923
research (908) 908
lupus erythematosus, systemic - blood (889) 889
magnetic resonance imaging (869) 869
surgery (851) 851
surveys and questionnaires (851) 851
pathology (850) 850
cytokines (848) 848
proteins (832) 832
autoantibodies - blood (830) 830
inflammation (822) 822
asthma - immunology (800) 800
lupus erythematosus, systemic - genetics (797) 797
allergic reaction (795) 795
pharmacology. drug treatments (790) 790
disease (784) 784
lupus erythematosus, systemic - drug therapy (780) 780
allergens (778) 778
infant, newborn (778) 778
genetic predisposition to disease (769) 769
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Genetically Distinct Subsets within ANCA-Associated Vasculitis
by Lyons, Paul A and Rayner, Tim F and Trivedi, Sapna and Holle, Julia U and Watts, Richard A and Jayne, David R.W and Baslund, Bo and Brenchley, Paul and Bruchfeld, Annette and Chaudhry, Afzal N and Cohen Tervaert, Jan Willem and Deloukas, Panos and Feighery, Conleth and Gross, Wolfgang L and Guillevin, Loic and Gunnarsson, Iva and Harper, Lorraine and Hrušková, Zdenka and Little, Mark A and Martorana, Davide and Neumann, Thomas and Ohlsson, Sophie and Padmanabhan, Sandosh and Pusey, Charles D and Salama, Alan D and Sanders, Jan-Stephan F and Savage, Caroline O and Segelmark, Mårten and Stegeman, Coen A and Tesař, Vladimir and Vaglio, Augusto and Wieczorek, Stefan and Wilde, Benjamin and Zwerina, Jochen and Rees, Andrew J and Clayton, David G and Smith, Kenneth G.C
The New England journal of medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 3, pp. 214 - 223
WEGENERS-GRANULOMATOSIS | PATHOGENESIS | SYSTEMIC VASCULITIS | ANTIBODY-ASSOCIATED VASCULITIS | DISEASE | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | PROTEINASE-3 | NEUTROPHILS | SMALL-VESSEL VASCULITIS | UMCG Approved | GENOME-WIDE ASSOCIATION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Genetic Predisposition to Disease | Genome-Wide Association Study | alpha 1-Antitrypsin - genetics | Major Histocompatibility Complex - genetics | Humans | Risk Factors | Male | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - genetics | Genotyping Techniques | Myeloblastin - genetics | Case-Control Studies | Granulomatosis with Polyangiitis - genetics | HLA-DP Antigens - genetics | Female | Polymorphism, Single Nucleotide | Microscopic Polyangiitis - genetics | Care and treatment | Autoantibodies | Vasculitis | Causes of | Genetic aspects | Diagnosis | Health aspects | Medical research | Statistical analysis | Disease | Pathogenesis | Proteinase | Granulomatosis | Major histocompatibility complex | Quality control | Antineutrophil cytoplasmic antibodies | Peroxidase | Histocompatibility antigen HLA | Wegener's granulomatosis | Proteinase 3 | Index Medicus | Abridged Index Medicus | Urologi och njurmedicin | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
by Guillevin, Loïc and Pagnoux, Christian and Karras, Alexandre and Khouatra, Chahera and Aumaître, Olivier and Cohen, Pascal and Maurier, François and Decaux, Olivier and Ninet, Jacques and Gobert, Pierre and Quémeneur, Thomas and Blanchard-Delaunay, Claire and Godmer, Pascal and Puéchal, Xavier and Carron, Pierre-Louis and Hatron, Pierre-Yves and Limal, Nicolas and Hamidou, Mohamed and Ducret, Maize and Daugas, Eric and Papo, Thomas and Bonnotte, Bernard and Mahr, Alfred and Ravaud, Philippe and Mouthon, Luc and French Vasculitis Study Grp and French Vasculitis Study Group
The New England journal of medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 19, pp. 1771 - 1780
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Immunomodulators | Pharmacology. Drug treatments | Azathioprine - therapeutic use | Neoplasms - etiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Kaplan-Meier Estimate | Rituximab | Male | Secondary Prevention | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Infection - etiology | Adult | Female | Immunosuppressive Agents - adverse effects | Aged | Immunologic Factors - adverse effects | Maintenance Chemotherapy | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Dosage and administration | Vasculitis | Azathioprine | Comparative analysis | Drug therapy | Patient outcomes | Glucocorticoids | Granulomatosis | Disease management | Patients | Inflammatory diseases | Cyclophosphamide | Pancreatic cancer | Antineutrophil cytoplasmic antibodies | Sepsis | Remission | Methotrexate | Cytoplasm | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: Identifying systemic sclerosis as a unique phenotype
by Chung, Lorinda and Liu, Juliana and Parsons, Lori and Hassoun, Paul M and McGoon, Michael and Badesch, David B and Miller, Dave P and Nicolls, Mark R and Zamanian, Roham T
Chest, ISSN 0012-3692, 12/2010, Volume 138, Issue 6, pp. 1383 - 1394
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Pneumology | Hypertension, Pulmonary - diagnosis | Age Distribution | Prevalence | Prognosis | Connective Tissue Diseases - epidemiology | Humans | Middle Aged | Male | Lupus Erythematosus, Systemic - therapy | Hypertension, Pulmonary - therapy | Cardiac Catheterization | Scleroderma, Systemic - physiopathology | Adult | Female | Registries | Retrospective Studies | Arthritis, Rheumatoid - diagnosis | Mixed Connective Tissue Disease - diagnosis | Severity of Illness Index | Risk Assessment | Comorbidity | Lupus Erythematosus, Systemic - epidemiology | California - epidemiology | Mixed Connective Tissue Disease - therapy | Arthritis, Rheumatoid - epidemiology | Scleroderma, Systemic - genetics | Connective Tissue Diseases - diagnosis | Connective Tissue Diseases - therapy | Hypertension, Pulmonary - epidemiology | Scleroderma, Systemic - epidemiology | Lupus Erythematosus, Systemic - diagnosis | Arthritis, Rheumatoid - therapy | Phenotype | Survival Analysis | Mixed Connective Tissue Disease - epidemiology | Sex Distribution | Aged | Longitudinal Studies | Systemic scleroderma | Connective tissue diseases | Analysis | Scleroderma (Disease) | Genetic aspects | Diagnosis | Pulmonary hypertension | Risk factors | Index Medicus | Abridged Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Chronic granulomatous disease as a risk factor for autoimmune disease
by De Ravin, Suk See, MD, PhD and Naumann, Nora, MD and Cowen, Edward W., MD, MHSc and Friend, Julia, MPH, PA-C and Hilligoss, Dianne, RN, MSN, CRNP and Marquesen, Martha, NP and Balow, James E., MD and Barron, Karyl S., MD and Turner, Maria L., MD and Gallin, John I., MD and Malech, Harry L., MD
Journal of allergy and clinical immunology, ISSN 0091-6749, 2008, Volume 122, Issue 6, pp. 1097 - 1103
Allergy and Immunology | antiphospholipid syndrome | Chronic granulomatous disease | IgA nephropathy | juvenile idiopathic nephropathy | autoimmune | lupus | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Biological and medical sciences | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Humans | Risk Factors | Pericardial Effusion - pathology | Male | Granulomatous Disease, Chronic - therapy | Lung Diseases - therapy | Granulomatous Disease, Chronic - complications | Autoimmune Diseases - etiology | Lung Diseases - etiology | Pericardial Effusion - therapy | Adolescent | Autoimmune Diseases - therapy | Adult | Female | Pericardial Effusion - etiology | Lung Diseases - pathology | Autoimmune Diseases - pathology | Granulomatous Disease, Chronic - pathology | Lupus | Rheumatoid factor | Respiratory tract diseases | Arthritis | Kidney diseases | Immunoglobulin A | Risk factors | Proteins | Anticoagulants | Pain | Medical imaging | Headaches | Ear diseases | Infections | Autoimmune diseases | Thrombosis | Patients | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
by Specks, Ulrich and Merkel, Peter A and Seo, Philip and Spiera, Robert and Langford, Carol A and Hoffman, Gary S and Kallenberg, Cees G.M and St. Clair, E. William and Fessler, Barri J and Ding, Linna and Viviano, Lisa and Tchao, Nadia K and Phippard, Deborah J and Asare, Adam L and Lim, Noha and Ikle, David and Jepson, Brett and Brunetta, Paul and Allen, Nancy B and Fervenza, Fernando C and Geetha, Duvuru and Keogh, Karina and Kissin, Eugene Y and Monach, Paul A and Peikert, Tobias and Stegeman, Coen and Ytterberg, Steven R and Mueller, Mark and Sejismundo, Lourdes P and Mieras, Kathleen and Stone, John H and RAVE-ITN Res Grp and RAVE-ITN Research Group
The New England journal of medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
WEGENERS-GRANULOMATOSIS | MAINTENANCE | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Therapy for Hepatitis C Virus–Related Cryoglobulinemic Vasculitis
by Dammacco, Franco and Sansonno, Domenico
The New England journal of medicine, ISSN 0028-4793, 09/2013, Volume 369, Issue 11, pp. 1035 - 1045
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Viral hepatitis | Infectious diseases | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antiviral Agents - therapeutic use | Cryoglobulinemia - drug therapy | Humans | Vasculitis - drug therapy | Vasculitis - etiology | B-Lymphocytes - physiology | Hepacivirus - genetics | Hepatitis C - complications | Cryoglobulinemia - etiology | Drug Therapy, Combination | Plasmapheresis | Monoclonal antibodies | Cryoglobulinemia | Care and treatment | Dosage and administration | Research | Hepatitis C | Genotype & phenotype | Vasculitis | Cryoglobulins | Interferon | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
by Stone, John H and Merkel, Peter A and Spiera, Robert and Seo, Philip and Langford, Carol A and Hoffman, Gary S and Kallenberg, Cees G.M and St. Clair, E. William and Turkiewicz, Anthony and Tchao, Nadia K and Webber, Lisa and Ding, Linna and Sejismundo, Lourdes P and Mieras, Kathleen and Weitzenkamp, David and Ikle, David and Seyfert-Margolis, Vicki and Mueller, Mark and Brunetta, Paul and Allen, Nancy B and Fervenza, Fernando C and Geetha, Duvuru and Keogh, Karina A and Kissin, Eugene Y and Monach, Paul A and Peikert, Tobias and Stegeman, Coen and Ytterberg, Steven R and Specks, Ulrich and RAVE-ITN Res Grp and RAVE-ITN Research Group
The New England journal of medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 221 - 232
WEGENERS-GRANULOMATOSIS | B-CELLS | ANTIBODY-ASSOCIATED VASCULITIS | THERAPY | RANDOMIZED-TRIAL | GRANULOMATOSIS ETANERCEPT TRIAL | SYSTEMIC VASCULITIDES | INDUCTION | UMCG Approved | CELL-ACTIVATION | REMISSION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Antibodies, Monoclonal, Murine-Derived | Double-Blind Method | Administration, Oral | Rituximab | Remission Induction | B-Lymphocytes - drug effects | Intention to Treat Analysis | Microscopic Polyangiitis - drug therapy | Quality of Life | Granulomatosis with Polyangiitis - drug therapy | Immunosuppressive Agents - adverse effects | Aged | Neoplasms - epidemiology | Prednisone - therapeutic use | Antibodies, Antineutrophil Cytoplasmic - blood | Autoantibodies | Vasculitis | Research | Comparative analysis | Drug therapy | Patient outcomes | Disease | Clinical trials | Lymphocytes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
by Jones, Rachel B and Cohen Tervaert, Jan Willem and Hauser, Thomas and Luqmani, Raashid and Morgan, Matthew D and Peh, Chen Au and Savage, Caroline O and Segelmark, Mårten and Tesar, Vladimir and van Paassen, Pieter and Walsh, Michael and Walsh, Dorothy and Westman, Kerstin and Jayne, David R.W and European Vasculitis Study Grp and European Vasculitis Study Group
The New England journal of medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 211 - 220
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Incidence | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Antibodies, Monoclonal, Murine-Derived | Glomerular Filtration Rate | Kidney Diseases - drug therapy | Rituximab | Kidney Diseases - mortality | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | B-Lymphocytes - drug effects | Intention to Treat Analysis | Immunosuppressive Agents - adverse effects | Aged | Infusions, Intravenous | Cyclophosphamide | Vasculitis | Research | Comparative analysis | Drug therapy | Clinical trials | Medical treatment | Mortality | Regulatory approval | Index Medicus | Abridged Index Medicus | Urologi och njurmedicin | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights